The clinical AAV pipeline for neurological diseases

At least 19 AAV gene therapies are in clinical trials for neurological conditions, spread across neurodegenerative diseases such as Parkinson’s, and rare conditions such as Batten disease.

Neurology is a top disease area among new gene therapy companies, and it is also one of the biggest for adeno-associated virus (AAV) vectored gene therapies in the clinic...